Urelumab
Product Specifications
CAS Number
934823-49-1
Target
Others, TNF
Related Pathways
Others, Apoptosis
Purity
0.977
Bioactivity
Urelumab (BMS-66513) is a humanized IgG4 monoclonal antibody, often used as a CD137 agonist.Urelumab has potential antitumor activity, potentiating tumor cell killing by T-cells and natural killer cells, and enhancing the cytotoxicity of Rituximab.Urelumab has been used in the study of solid tumor-related diseases such as diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL) . Urelumab can be used to study diseases associated with solid tumors such as diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL) .
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
![Methyl 2-exo- (8-benzyl-6,6-difluoro-8-azabicyclo[3.2.1]octan-3-yl) acetate](https://cdn.genprice.uk/genprice/uk/genprice2.webp)
orb3031731-01 200 mg
Methyl 2-exo- (8-benzyl-6,6-difluoro-8-azabicyclo[3.2.1]octan-3-yl) acetate
Sign In for Pricing
View Details orb3031731-02 5 mg
Methyl 2-exo- (8-benzyl-6,6-difluoro-8-azabicyclo[3.2.1]octan-3-yl) acetate
Sign In for Pricing
View Details orb3031731-03 25 mg
Methyl 2-exo- (8-benzyl-6,6-difluoro-8-azabicyclo[3.2.1]octan-3-yl) acetate
Sign In for Pricing
View Details 